SummitTX Capital’s BioLife Solutions BLFS Stock Holding History

SummitTX Capital’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,266	Closed	-$1.75M	–	781
2025 Q4	$1.75M	Buy	+72,266	New	+$1.89M	0.05%	329

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SummitTX Capital's BLFS Position: Q1 2026 in Review

SummitTX Capital sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 72,266 shares — an estimated $1.75M sold.

SummitTX Capital first reported a position in BLFS in Q4 2025 and held it in 1 quarter. The position peaked at $1.75M in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

SummitTX Capital reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
SummitTX Capital sold 72,266 BioLife Solutions shares in Q1 2026, an estimated $1.75M.
SummitTX Capital first reported a position in BioLife Solutions in Q4 2025 and held it in 1 quarter.
SummitTX Capital's BioLife Solutions position peaked at $1.75M in Q4 2025.
187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.